# HemaSphere

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/hemasphere/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 2572-9241 |
| ISSNs | 2572-9241 |
| OpenAlex ID | https://openalex.org/S4210211592 |
| Publisher | Wolters Kluwer |

## Journal papers

- [PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION](https://scholariq.org/papers/pb2056-prevalence-of-clinically-significant-extravascular-hemolysis-in-stable-c5/)
- [P944: REAL-WORLD PATIENT CHARACTERISTICS AND SURVIVAL OUTCOMES OF LENALIDOMIDE REFRACTORY VS. LENALIDOMIDE EXPOSED RRMM PATIENTS IN THE HONEUR FEDERATED DATA NETWORK](https://scholariq.org/papers/p944-real-world-patient-characteristics-and-survival-outcomes-of-lenalidomide/)
- [PF718 THE ECONOMIC AND HUMANISTIC BURDEN OF GRAFT‐VERSUS‐HOST DISEASE (GVHD) IN PEDIATRIC PATIENTS: A SYSTEMATIC LITERATURE REVIEW (SLR)](https://scholariq.org/papers/pf718-the-economic-and-humanistic-burden-of-graft-versus-host-disease-gvhd-in/)
- [P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA](https://scholariq.org/papers/p979-patient-reported-outcomes-for-teclistamab-versus-real-world-physician-s/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.